Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -17.99% is 75% above its 5-year average of -72.13%, near the high end of its 5-year range (-147.18%–-4.20%).
As of the fiscal period ended Tuesday, June 30, 2026. 50.77% above its 12-month average of -36.54%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -17.99%.
RETURN ON INVESTED CAPITAL (ROIC)
-17.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-36.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-53.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-72.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-66.46%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+50.77%
CURRENT VS 3Y AVG
+66.49%
CURRENT VS 5Y AVG
+75.05%
CURRENT VS 10Y AVG
+72.93%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 644 covered companies
CURRENT VS SECTOR MEDIAN
+46.11%
vs the sector median at left
Cibus, Inc.
Market Cap
$122.13M
Return on Invested Capital (ROIC)
-17.99%
TTM Avg
-36.54%
3Y Avg
-53.69%
5Y Avg
-72.13%
Market Cap
$122.59M
Return on Invested Capital (ROIC)
-1.78%
TTM Avg
-41.34%
3Y Avg
-32.26%
5Y Avg
-28.21%
Market Cap
$124.91M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-346.83%
3Y Avg
-231.85%
5Y Avg
-139.34%
Market Cap
$121.00M
Return on Invested Capital (ROIC)
-137.40%
TTM Avg
-133.78%
3Y Avg
-372.93%
5Y Avg
-315.43%
Market Cap
$127.91M
Return on Invested Capital (ROIC)
-82.87%
TTM Avg
-100.14%
3Y Avg
-98.73%
5Y Avg
-97.80%
Market Cap
$118.80M
Return on Invested Capital (ROIC)
-61.84%
TTM Avg
-30.30%
3Y Avg
-57.06%
5Y Avg
-116.42%
Market Cap
$118.02M
Return on Invested Capital (ROIC)
-223.06%
TTM Avg
-221.51%
3Y Avg
-125.15%
5Y Avg
-99.68%
Market Cap
$130.05M
Return on Invested Capital (ROIC)
-21.42%
TTM Avg
-8.92%
3Y Avg
-14.86%
5Y Avg
-16.42%
Market Cap
$117.53M
Return on Invested Capital (ROIC)
-87.72%
TTM Avg
-74.88%
3Y Avg
-52.32%
5Y Avg
-62.32%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cibus, Inc. (CBUS) | $122.13M | -17.99% | -36.54% | -53.69% | -72.13% |
| enGene Holdings Inc. (ENGN)vs › | $122.59M | -1.78% | -41.34% | -32.26% | -28.21% |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $124.91M | N/A | -346.83% | -231.85% | -139.34% |
| TuHURA Biosciences, Inc. (HURA)vs › | $121.00M | -137.40% | -133.78% | -372.93% | -315.43% |
| Entera Bio Ltd. (ENTX)vs › | $127.91M | -82.87% | -100.14% | -98.73% | -97.80% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.80M | -61.84% | -30.30% | -57.06% | -116.42% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $118.02M | -223.06% | -221.51% | -125.15% | -99.68% |
| Health Catalyst, Inc. (HCAT)vs › | $130.05M | -21.42% | -8.92% | -14.86% | -16.42% |
| Caribou Biosciences, Inc. (CRBU)vs › | $117.53M | -87.72% | -74.88% | -52.32% | -62.32% |
| Genelux Corporation (GNLX)vs › | $116.36M | -192.18% | -186.03% | -161.77% | -220.86% |
ROIC
-18.0%
ROE
-663.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -17.99% |
| 2026-03-31 | -18.83% |
| 2025-12-31 | -30.35% |
| 2025-09-30 | -29.96% |
| 2025-06-30 | -85.60% |
| 2025-03-31 | -89.55% |
| 2024-12-31 | -78.15% |
| 2024-09-30 | -147.18% |
| 2024-06-30 | -63.36% |
| 2024-03-31 | -65.03% |
| 2023-12-31 | -60.86% |
| 2023-09-30 | -6.85% |
| 2023-06-30 | -4.20% |
| 2023-03-31 | -121.52% |
| 2022-12-31 | -107.76% |
| 2022-09-30 | -114.65% |
| 2022-06-30 | -96.38% |
| 2022-03-31 | -89.30% |
| 2021-12-31 | -90.70% |
| 2021-09-30 | -103.58% |
| 2021-06-30 | -92.82% |
| 2021-03-31 | -92.74% |
| 2020-12-31 | -77.58% |
| 2020-09-30 | -78.19% |
| 2020-06-30 | -69.98% |
| 2020-03-31 | -60.01% |
| 2019-12-31 | -48.97% |
| 2019-09-30 | -40.10% |
| 2019-06-30 | -33.81% |
| 2019-03-31 | -29.56% |
| 2018-12-31 | -25.15% |
| 2018-09-30 | -22.33% |
| 2018-06-30 | -25.48% |
| 2018-03-31 | -39.62% |
| 2017-12-31 | -37.97% |
| 2017-09-30 | -33.41% |
| 2017-06-30 | -162.81% |
| 2017-03-31 | -111.71% |
| 2016-12-31 | -88.01% |
